Casey T. Weaver
Corporate Officer/Principal bij The University of Alabama School of Medicine
Profiel
Casey T.
Weaver is the founder of Sesen Bio, Inc. (founded in 2008).
Currently, Dr. Weaver is a Professor at The University of Alabama School of Medicine (since 1992).
Previously, Dr. Weaver worked as an Assistant Professor at the University of Washington.
Dr. Weaver received undergraduate and doctorate degrees from the University of Florida.
Actieve functies van Casey T. Weaver
| Bedrijven | Functie | Begin |
|---|---|---|
| The University of Alabama School of Medicine | Corporate Officer/Principal | 01-01-1992 |
Eerdere bekende functies van Casey T. Weaver
| Bedrijven | Functie | Einde |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
| CARISMA THERAPEUTICS, INC. | Oprichter | - |
Opleiding van Casey T. Weaver
| University of Florida | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
